MASSARI, SERENA
 Distribuzione geografica
Continente #
AS - Asia 4.973
NA - Nord America 3.804
EU - Europa 2.857
SA - Sud America 388
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 12.097
Nazione #
US - Stati Uniti d'America 3.713
CN - Cina 2.492
SG - Singapore 1.256
IT - Italia 661
VN - Vietnam 410
IE - Irlanda 399
RU - Federazione Russa 371
HK - Hong Kong 358
SE - Svezia 325
BR - Brasile 304
UA - Ucraina 216
DE - Germania 190
FR - Francia 145
FI - Finlandia 129
GB - Regno Unito 104
KR - Corea 88
BE - Belgio 73
IN - India 69
PL - Polonia 46
BD - Bangladesh 44
AT - Austria 42
TR - Turchia 41
CA - Canada 39
MX - Messico 37
RO - Romania 35
JP - Giappone 33
NL - Olanda 30
AR - Argentina 29
IQ - Iraq 27
SA - Arabia Saudita 27
PK - Pakistan 26
ES - Italia 23
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
ID - Indonesia 16
ZA - Sudafrica 14
CH - Svizzera 13
EC - Ecuador 13
CI - Costa d'Avorio 11
CO - Colombia 11
CL - Cile 9
ET - Etiopia 9
PH - Filippine 9
VE - Venezuela 9
EG - Egitto 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
LB - Libano 7
GR - Grecia 6
LV - Lettonia 6
JO - Giordania 5
PA - Panama 5
IR - Iran 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
AL - Albania 3
AO - Angola 3
CR - Costa Rica 3
DZ - Algeria 3
EU - Europa 3
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
GE - Georgia 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LY - Libia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
Totale 12.087
Città #
Guangzhou 2.081
Singapore 935
Chandler 572
Dublin 399
Perugia 397
San Jose 367
Hong Kong 346
Dong Ket 243
Ashburn 220
San Mateo 201
Boardman 152
Santa Clara 136
Jacksonville 110
Beijing 102
Moscow 97
Lauterbourg 90
Medford 89
Princeton 88
Seoul 85
Altamura 82
Los Angeles 78
Brussels 73
Ann Arbor 71
The Dalles 71
Ho Chi Minh City 62
Munich 61
Lawrence 60
Wilmington 60
New York 50
Fremont 44
São Paulo 43
Andover 41
West Jordan 38
Piscataway 37
Hanoi 33
Helsinki 33
Redmond 31
Vienna 31
Council Bluffs 30
Orem 30
Tokyo 29
Turku 29
Warsaw 28
Bucharest 26
Saint Petersburg 25
Dearborn 23
Brooklyn 21
Dallas 20
Norwalk 20
Atlanta 18
Hefei 18
Montreal 18
Ankara 17
Redwood City 17
Spoleto 16
Dhaka 15
Houston 15
Phoenix 15
Rome 15
Chennai 14
Chicago 14
Denver 13
Des Moines 13
Buffalo 12
Manchester 12
Nuremberg 12
Riyadh 12
Secaucus 12
Abidjan 11
Baghdad 11
Hanover 11
London 11
Mexico City 11
Poplar 11
Tashkent 11
Porto Alegre 10
Woodbridge 10
Amsterdam 9
Columbus 9
Da Nang 9
Izmir 9
Jeddah 9
Seattle 9
Shanghai 9
Stockholm 9
Addis Ababa 8
Charlotte 8
Johannesburg 8
Lappeenranta 8
Mumbai 8
Olomouc 8
Rio de Janeiro 8
Toronto 8
Barnet 7
Belo Horizonte 7
Den Haag 7
Haiphong 7
Lahore 7
Querétaro 7
Radomsko 7
Totale 8.550
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.139
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 329
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 317
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 200
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 181
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 154
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 145
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 142
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 142
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 141
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 139
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 138
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 137
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 135
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 133
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 132
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 129
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 126
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 124
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 124
6-Desfluoroquinolones as promising HIV transcription inhibitors 123
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 122
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 120
Acting on Tat-Mediated Transcription to Achieve a Long Term Control of HIV-1 Latency 116
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 115
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 115
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 114
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 112
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 112
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 111
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 111
A new quinolone derivative with ultra-potent anti-HIV activity. 110
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 110
A New Derivative with Ultra-Potent Anti-HIV Activity 109
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps. 109
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 109
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 109
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 108
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 107
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 104
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 104
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 103
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 101
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 101
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 100
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 98
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 98
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 97
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 97
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 96
6-Aminoquinolones targeting HCV NS5B polymerase. 96
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 95
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 95
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 93
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 92
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 92
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 92
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 90
New compounds targeting the rna polymerase of influenza a and b viruses. 90
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 89
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 87
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 86
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 86
The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication 86
In Vitro effects of alternative smoking devices on oral cells: Electronic cigarette and heated tobacco product versus tobacco smoke 85
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 85
Phospholipidosis effect of drugs by adsorption into lipid monolayers 84
Cycloheptathiophene-3-carboxamide derivatives as influenza A virus polymerase inhibitors 83
Biotinylated Tryptophan Catabolites for Target Fishing. 83
Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy 82
Nuovi 6-DFQ come inibitori della Transattivazione dell’HIV-1 82
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 79
Compounds for use in the treatment of cancer and inflammatory conditions 79
Structural Investigation of Cycloheptathiophene-3-carboxamide Derivatives Targeting Influenza Virus Polymerase Assembly 77
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 77
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 75
TARGETING CDKs TO INHIBIT THE HIV-1 TAT-MEDIATED TRANSCRIPTION 75
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate 74
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 74
Design, Synthesis, and Evaluation of WC5 Analogues as Inhibitors of Human Cytomegalovirus Immediate-Early 2 Protein, a Promising Target for Anti-HCMV Treatment 74
Triazolopyrimidine nuclei: privileged scaffolds for developing antiviral agents with a proper pharmacokinetic profile. 74
Disegno e sintesi di agenti anti-HIV a duplice attività 73
Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity. 73
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 70
Small molecole targeting HPV E6 and E7 oncoproteins expression. 70
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 69
Q-raKtion: A Semiautomated KNIME Workflow for Bioactivity Data Points Curation 68
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-protein Interaction as a Target for Next-generation Anti-influenza Therapeutics. 68
Nuovi 6-DFQ come inibitori della transattivazione dell’HIV-1. Abstr O15 67
Targeting the HIV Tat-mediated transcriptional machinery: P-TEFb complex inhibitors 66
Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder. 65
SMALL MOLECULES TARGETING HPV E6 AND E7 ONCOPROTEINS EXPRESSION 64
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 64
Blocking HIV-1 Replication by Targeting the TAT-Hijacked Transcriptional Machinery 63
From Small to Powerful: The Fragments Universe and its "Chem-Appeal" 59
Studies on anti-HIV Quinolones 57
Ethyl 1,8-Naphthyridone-3-carboxylates Downregulate Human Papillomavirus-16 (HPV-16) E6 and E7 Oncogenes Expression 57
Protein-protein interactions by influenza polymerase subunits as drug targets 56
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives 51
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo 50
Totale 12.269
Categoria #
all - tutte 44.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021327 0 0 0 0 0 0 0 0 0 31 37 259
2021/2022940 31 144 18 66 73 7 24 242 69 35 111 120
2022/20231.588 96 281 19 161 155 151 3 102 514 15 57 34
2023/20242.830 39 116 37 24 14 22 2.246 16 57 57 78 124
2024/20251.852 19 150 65 139 186 108 246 121 305 113 254 146
2025/20263.548 239 245 173 476 506 345 647 216 446 255 0 0
Totale 12.449